Similar articles

• Letter by Bergerot et al Regarding Article, "Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".

  Bergerot C, Farhat F, Mewton N. Bergerot C, et al. Circulation. 2016 Feb 9;133(6):e392. doi: 10.1161/CIRCULATIONAHA.115.018316. Circulation. 2016. PMID: 26858298 No abstract available.
• Letter by Poullis Regarding Article, "Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".

  Poullis M. Poullis M. Circulation. 2016 Feb 9;133(6):e391. doi: 10.1161/CIRCULATIONAHA.115.018190. Circulation. 2016. PMID: 26858297 No abstract available.
• Response to Letters Regarding Article, "Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".

  Zheng Z, Zhang H, Yuan X, Zhang H, Chen S, Zhao Y, Hua K, Rao C, Wang W, Sun H, Hu S. Zheng Z, et al. Circulation. 2016 Feb 9;133(6):e394-5. doi: 10.1161/CIRCULATIONAHA.115.019468. Circulation. 2016. PMID: 26858300 No abstract available.
• Efficacy of β-blocker therapy for secondary prevention for patients undergoing coronary artery bypass grafting surgery.

  Sun C, Zhang H, Zheng Z. Sun C, et al. Curr Opin Cardiol. 2016 Nov;31(6):654-661. doi: 10.1097/HCO.0000000000000338. Curr Opin Cardiol. 2016. PMID: 27748695 Review.
• Effect of beta blockers after coronary artery bypass in postinfarct patients: what can we learn from available literature?

  Geraci SA, Haan CK. Geraci SA, et al. Ann Thorac Surg. 2002 Nov;74(5):1727-32. doi: 10.1016/s0003-4975(02)03992-9. Ann Thorac Surg. 2002. PMID: 12440651 Review.